A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT ID: NCT00901979
Last Updated: 2013-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
693 participants
INTERVENTIONAL
2009-04-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
NCT01169090
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
NCT00700817
Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
NCT01422590
Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
NCT02719756
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
NCT01937598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LCQ908 Dose 1
LCQ908A
metformin
LCQ908 Dose 2
LCQ908A
metformin
LCQ908 Dose 3
LCQ908A
metformin
LCQ908 Dose 4
LCQ908A
metformin
LCQ908 Dose 5
LCQ908A
metformin
Placebo
Placebo
metformin
Sitagliptin
Sitagliptin
metformin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LCQ908A
LCQ908A
LCQ908A
LCQ908A
LCQ908A
Placebo
Sitagliptin
metformin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Advantage
Mesa, Arizona, United States
Mesa Family Medical Center/Clinical Research Advantage
Mesa, Arizona, United States
Woodland International Reserach Group, LLC
Little Rock, Arkansas, United States
Associated Pharmaceutical Research
Buena Park, California, United States
John Muir Clinical Research
Concord, California, United States
*Private Practice*
Pasadena, California, United States
Apex Research of Riverside
Riverside, California, United States
California Research Foundation
San Diego, California, United States
CNRI-San Diego, LLC
San Diego, California, United States
Orange County Research Center
Tustin, California, United States
Diablo Clinical
Walnut Creek, California, United States
Denver VA Medical Center
Denver, Colorado, United States
Complete Family Care
Northglenn, Colorado, United States
Research Center Phase I-IV of Florida, Corp.
Miami, Florida, United States
Metabolic Research Institute, Inc.
West Palm Beach, Florida, United States
Perimeter North Medical Research
Roswell, Georgia, United States
MacNeal Center for Clinical Research
Berwyn, Illinois, United States
Venture Resource Group
Overland Park, Kansas, United States
Cotton-O'Neil Clinical Research Center Topeka KS United States
Topeka, Kansas, United States
Graves Gilbert Clinic Bowling Green KY United States
Bowling Green, Kentucky, United States
Commonwealth Biomedical Research, LLC
Madisonville, Kentucky, United States
Centennial Medical Group
Elkridge, Maryland, United States
International Research Center Towson MD United States
Towson, Maryland, United States
Fallon Clinic Worcester MA United States
Worcester, Massachusetts, United States
Southwestern Medical Clinic
Bridgman, Michigan, United States
Clarkston Medical Group
Clarkston, Michigan, United States
Michigan State University - Kalamazoo Ctr for Med Studies
Kalamazoo, Michigan, United States
Mississippi Medical Research, LLC
Picayune, Mississippi, United States
ClinVest Research
Springfield, Missouri, United States
St. John's Clinic - Medical Research
Springfield, Missouri, United States
Montana Medical Research
Missoula, Montana, United States
Meera Dewan, P.C.
Omaha, Nebraska, United States
Libra Clinical Research Associates
Brick, New Jersey, United States
Physicians Research Center
Toms River, New Jersey, United States
Endwell Family Physician
Endwell, New York, United States
*Private Practice* Staten Island
Staten Island, New York, United States
Medical Frontiers LLC
Carlisle, Ohio, United States
Radiant Research
Greer, South Carolina, United States
Southwind Medical Specialists Memphis TN United States
Memphis, Tennessee, United States
Dallas Diabetic and Endocrinology Research Center
Dallas, Texas, United States
Radiant Research - North Dallas
Dallas, Texas, United States
Accurate Clinical Research
Houston, Texas, United States
Blalock Clinical Research
Houston, Texas, United States
Texas Center for Drug Development, P.A.
Houston, Texas, United States
Ettrick Health Center
Ettrick, Virginia, United States
McGuire Veterans Medical Center
Richmond, Virginia, United States
Northwest Clinical Research
Bellevue, Washington, United States
Providence Physicians Group
Monroe, Washington, United States
Health Sciences Centre - Diabetes Research Group
Winnipeg, Manitoba, Canada
Rivergrove Medical Clinic
Winnipeg, Manitoba, Canada
Credit Valley Prof Bldg
Mississauga, Ontario, Canada
Hamilton Medical Research Group
Sherbrooke, Ontario, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Institut de Recherches Cliniques
Montreal, Quebec, Canada
Clinique Médicale Millénia Santé
Québec, Quebec, Canada
CHUS - Hopital Fleurimont
Sherbrooke, Quebec, Canada
Azienda Ospedaliera-Ospedali Riuniti di Bergamo
Bergamo, , Italy
Centro Studi sull'Invecchiamento CeSI-Univers.G.D'Annunzio
Chieti, , Italy
A.O.Polo Universitario Luigi Sacco
Milan, , Italy
Istituto Scientifico San Raffaele - IRCCS
Milan, , Italy
Ospedale S.Giovanni di Dio
Olbia, , Italy
Presidio Ospedaliero di Cisanello Università degli Studi
Pisa, , Italy
Univ.Tor Vergata - AUSL ROMA B - Sede Territoriale
Roma, , Italy
Samodzielny Publiczny Zaklad Opieki Zdrowotnej
Oława, , Poland
Policlinica Dr. Luis Rodriguez Carrasquillo
Carolina, , Puerto Rico
Endocrine Lipid Diabetes Research Institute Ponce PR United States
Ponce, , Puerto Rico
Miguel Sosa-Padilla, M.D.
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLCQ908A2203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.